Tom Jefferson: Covid-19—supermarket wisdom
The woman is speaking to me through a mask. Her voice is muffled. I know her by sight. I think her name is Anna and she is a nurse at […]
Search Results for: tom jefferson
Tom Jefferson: Covid 19—lockdown blues
Pietro is an academic friend in Rome. He lives in a flat and has been in lockdown for a week. He tells me he is slowly going crazy because his […]
Tom Jefferson: Covidair flight 19 from Rome to Oxford and back again
Antonio (not his real name) sits in the departure hall in Rome Fiumicino airport. He is one of those guys who wrap your luggage up in plastic. He initially complains […]
Tom Jefferson: Covid-19—we live in surreal times
To me, the term “surreal” means dream like reality. That is what I felt when sitting at a table in my local Chinese restaurant in Rome. I noticed the waiting […]
Tom Jefferson: Covid 19—many questions, no clear answers
Because of my background as an epidemiologist and Cochrane researcher, and my involvement in the H1N1 outbreak, I often get stopped in the street, or in a bar, or the […]
Tom Jefferson: How Cochrane is doing pharma a good turn
The way in which Cochrane produces its reviews is a boon to pharma, says Tom Jefferson […]
Tom Jefferson and Peter Doshi: RIP PubMed commons
Four years ago, the US National Institutes of Health (NIH) launched a pilot project to “leverage the social power of the internet to encourage constructive criticism and high quality discussions.” The service […]
Kamal R Mahtani, Tom Jefferson, and Carl Heneghan: What makes a systematic review “complex”?
Kamal R Mahtani, Tom Jefferson, and Carl Heneghan reflect on the lack of definitions, and propose a solution […]
Tom Jefferson: The UK turns to Witty, Vallance, and Van Tam for leadership: revolving doors?
Revolving doors are used to facilitate entry or exit into a building. The trick with using these doors is always to get your timing right. Too fast or too slow […]
Tom Jefferson: Adapting pharmaceutical regulation to more transparency
On the 8 December the European Medicines Agency (EMA) and the EU Commission hosted a workshop to discuss Adaptive Pathways, formerly known as Adaptive Licensing. The 180 physical and 155 […]